Carmel Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Carmel Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$73.94 - $80.67 $13,826 - $15,085	187 New	187 $14,000
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $96,250 - $109,659	-1,245 Reduced 39.69%	1,892 $156,000
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $195,497 - $280,667	3,137 New	3,137 $0
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $186,039 - $233,126	-3,212 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $208,394 - $236,531	3,212 New	3,212 $233,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Carmel Capital Partners, LLC with notifications on news.